← Open Payments lookup

INGRIDA PAKALNISKYTE: Open Payments

NPI 1598836371 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$674 in 34 payments from 20 companies in 2025. Trend: 2023 $145 · 2024 $335 · 2025 $674

Food & beverage: $674
CompanyPaymentsAmount
Merck Sharp & Dohme LLC4$73
Novartis Pharmaceuticals Corporation1$65
BeOne Medicines USA, Inc.3$52
GlaxoSmithKline, LLC.3$49
Genentech USA, Inc.2$48
SERVIER PHARMACEUTICALS LLC2$45
Daiichi Sankyo Inc.2$39
AstraZeneca Pharmaceuticals LP2$39
Janssen Biotech, Inc.2$37
ABBVIE INC.2$35

Products named: KEYTRUDA, KISQALI, Enhertu, RYBREVANT, TEVIMBRA, JEMPERLI, VERZENIO, Polivy.

Industry payments across NE — which companies pay providers there.